熊 张
Founded in May 1989, China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) is the national indUnited Statestrial association in China devoted to promote international trade and investment in the healthcare sector.
CCCMHPIE has a diverse membership including the major R&D facilities, manufactures, trading companies and investment institutions in China, ranging from pharmaceuticals, medical devices and equipment, biopharmaceuticals, traditional Chinese medicines, nutraceuticals, functional cosmetics to foods for special medical purposes. It is a professional trade and investment promotion organization in the Chinese healthcare sector while serving as the bridge between authorities and enterprises as well as Chinese and foreign partners.
CCCMHPIE has a diverse membership including the major R&D facilities, manufactures, trading companies and investment institutions in China, ranging from pharmaceuticals, medical devices and equipment, biopharmaceuticals, traditional Chinese medicines, nutraceuticals, functional cosmetics to foods for special medical purposes. It is a professional trade and investment promotion organization in the Chinese healthcare sector while serving as the bridge between authorities and enterprises as well as Chinese and foreign partners.
China Chamber of Commerce for Import and Export of Medicines and Health Products
副主任尧 徐
启瑞药业作为国家高新技术企业,先后承担了包括国家级创新药物孵化基地—武汉启瑞国际化集成创新药物孵化基地在内的7项国家“重大新药创制”科技重大专项项目(该孵化基地为中南地区唯一的以企业牵头的国家级新药孵化基地),以及国家科技部高校人才服务企业项目,国家发改委、国家工信部产业化项目、技改项目,湖北省、武汉市重大科技专项、重点产品产业化项目等二十余项;同时建立了省级企业技术中心、心血管药物工程研究中心、校企共建研发中心等平台。获得了“国家级创新型试点企业”、“国家火炬计划重点高新技术企业”、“国家博士后工作站”、“国家级技术创新示范企业”、“湖北省科技型中小企业成长路线图计划重点培育企业”、湖北省创新型企业、湖北省科技创业优秀企业、湖北省著名商标、湖北省科技型中小企业创新奖、武汉市“重点纳税户”、武汉名牌产品、武汉市“守合同重信用企业”、武汉市江夏区“立功单位”等认证和荣誉。
武汉启瑞药业
bd总监梦龄 徐
Investment management company commits to authentic relationships, communications, and promises,builds productive operations and profitable businesses,invests in the field of medical technology, new energy source etc.
JIAYUHONGDE INVESTMENT (SHANGHAI)Ltd
高级投资经理李 怡
Stated-owned large pharmaceutical corporation, covering R&D, manufacture, and sales of chemical and biological medicine.